Member Info for alfista

An Interesting prediction that at least can be measured against.

As for "dealing with people who will run rings around the clowns", as DSM are responsible for all dealings with brands, and given the high profile they have given to Fruitflow (as evidenced in links kindly posted up by gixer only a day ago).

What is your justification for referring to DSM as clowns? Or to accuse them of moribund management.
Did you know, when you bought shares, how quickly or slowly major brands adopt new health ingredients? If you did, you have never once written anything on this board to support your claimed expertise.

Oh dear, my fault for putting the first comment on WRN foir months.
Grow up fonters, you lost your money there you child.

For the record, nope.

Tp pinch Shaggy's line.
Wasn't me

Does the result depend on the outcome here, or is it the outcome that depends on the result.
Fruitflow's success will be affected by the type of product launch. So far there hasn't been a recognisably big brand launch, Those who think there never will be will have one opinion on the prospect of Provexis, those who believe that there will be will hold an opposing view. A Tootight says, optimism has appeared a few times, but not for the key reason, so it wasn't sustained. The only thing that will bring a sustained rise is an obvious revenue generator, i.e a large well promoted leading brand launch.

That's what everyone hoped for. Some left because the grass was greener, some bought more because their timescales were longer.

Each to their own, all the Persecuted Puks in the world won't affect a thing on the tiny volumes of late. Seems that most remaining holders are playing the waiting game.

I agree with that. What would anyone be buying in to? A company where the vast majority of shares are held by another company, giving them the ability to run the show. The only news that has been available in the last few months is news that would be removed if published here. Joining Britdaq involves telling untruths unless one is a HNWI /Sophisticated Investor. Only investment is in a company that is consuming cash at a rate, and whose shares are illiquid. Where is the temptation to buy in to that lot?

Bern.
If I were to cut one of my products following the line of the sp here, it would look absolutely nothing like a 45 degree cut.
So when you say, with all the authority you always grant to yourself, that he is not wrong, I'm sorry but I think you are just saying that because of the writer If he wants to use a spike of a few days as the real situation, is that a fair reflection, or is it a distortion. I agree that the day traders came here to play when the By Health deal was announced, but they were only here for a very brief time. Put it this way, if I had written at that time that the sp was showing a 45 degree upward line, you'd have accused me of all sorts, wouldn't you?

Oh, OK, he claimed that the sp had been in sharp decline for two years, provably incorrect, so what would you call it?
It's a bit odd to me that you seem to think someone distorting things like that is tolerable on a share you own.
Whatever.

More disingenuous comments, in fact the share was at its low around 2 years ago, the chairman took part in a placing along with some other investors.
Puk says he can't read the replies, good job, because calling him out usually caused much throwing of toys.

The expansion of Provexis Retail in the half year to end of September has been totally discounted/ignored. In the period, income from product support goes on to the plus side of the balance, but equally product support handed on to H&B may or may not counter it. Clearly that would have a material effect on losses reduction, or indeed increase. At best, a wild guess, at worst, deliberate disinformation.

By Health are working on Blue Cap accreditation to allow 2019 product launches, therefore highly inaccurate to describe (with no evidence at all) progress in China to be years away.

For the moment, having increased holdings in the placing, there is no sign of further appetite from the HNWI to increase his holding. Neither is there any sign of anyone disposing. A quiet spell.

The investors have backed a growth strategy.
So the company uses the funding to expand market reach, increasing turnover whilst maintaining a strong gross profit margin. Once the expansion has reached the aimed for level, the funding required to achieve it is not needed, achieving a dramatic effect on bottom line. There has been more gross profit in every year. Question is, when will the company slow down its growth? Or will it be sold to a larger entity long before?

The inflow for marketing support will surely be balanced by that support being passed on to H&B ?
So, although revenues will increase, that doesn't necessarily mean an addition to net earnings. If, in that period, there has been the cost of launch, but not the income from it, then the neggies will have another play day. Other revenues, from DSM and Provexis Retail, may also have increased, which is the background detail we need.

You can see that DSM give support to brand launches, this has an effect on early stage revenues. Obs.

How do you justify that comment when you have seen funds raised with no apparent issue very recently? Plus the addition of another major holder. I honestly can't understand why you see gloom where it simply doesn't exist.

Institutional Investor increasing their holding as expected.
Strong support from the big lads.

There we go, placing achieved with no drama.
Growth will exceed the planned yoy of 20% this year.
How long before SiS is the target for a bigger brand? The enlarged group will not have escaped the notice of other companies IMHO

A doubling of the size of the company by acquisition of a premium brand.
Yep, disaster. Sp will recover post placing.

Can I make clear yet again, I DID NOT "get your post removed". One of mine was also removed.
Paranoid?

A more considered view of this disposal throws up a couple of points.

The disposal is equivalent to around 10% of the market cap.

The profit contribution was only 5% of the total
.
As Broadcare was grown in house in the "Innovation incubator", it reflects well on the wisdom of creating that facility.

Should the sum received be applied directly to bank borrowing, the material reduction in debt adds greatly to the security and stability of the core business.

Sound business IMHO

As you were a Provexis holder, and a Moon hater, why have you continued to hold?
Makes zero sense to me. If you felt that strongly, why not take your funds to a share that you are content with?

Reddragon is entitled to his opinion, the company has grown from a cottage industry to a fast growing global presence. Up to each individual if they like what they see or not. By the way, dilution is not dilution if the extra shares are backed by an asset of equal, or greater, value than the new shares. In this case they are, it is a shrewd acquisition IMHO

One of the key factors in the expansion of SiS has been strong support from II investors.
I don't really think the petty points scoring posts on here have any effect whatsoever.
Market presence doubled, earnings enhancing, strong positives.
Pricing of the placing is a bit disappointing, recovery may have to wait until the results of being a doubled size company shake down to hard figures. In a growth industry, with a global reach, that shouldn't be too far in to the future.

I'd expect a shake down to placing price, at which point I'll consider adding. Others may consider selling if they think that doubling the size of the business is a bad thing. Each to their own.

Percy is very balanced. One day he says "we've all lost the lot", the next day he says "be greedy, fill your boots".
True comedy gold, and you agree with him in both views no doubt.

There is a value in being consistent
My consistent view is that just one of the right brand names launching a Fruitflow product will change sentiment. Investors have to decide whether they expect that to happen, and act accordingly. The disclosure that a HNWI had a substantial holding was welcome, but it isn't in itself a signal to buy, since we've had HNWI involvement running back for many years. That is plain fact. So, Percy fan club, what else changed to convert him from abject defeat to leading the cavalry charge? Or is that yet another evidence free claim that you feel no need to elucidate? Yep, thought so.

There, all can read, as if they didn't know already, your reasoning is driven by an illogical obsession with my posts.
Classic stalking.
The market is not predictable at all over a five year period, so your "perhaps" comments are nothing more than mischief making with other people's money. Shame on you. You know full well that I never have, and never will, advise anyone else what to do with their money. Totally up to each individual. You can't find a single post from me telling others what to buy or sell. Your nuisance value is diminished by you total lack of credibility IMHO